Healthtech

More news about this topic

Healthtech Quarterly

Healthtech Report: Commure’s $7 Billion Raise Headlines a Slow Quarter

July 27, 2026

The Q2 2026 Healthtech Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

Research

Learn more »
Healthtech Public Comp Sheet

Healthtech Public Comp Sheet: Q2 GLP-1 Winners, AI-Risk Laggards

July 22, 2026

Our Healthtech Public Comp Sheet tracks stock performances, valuations, and market caps of key publicly traded healthtech companies.

Research

Learn more »
Analyst Note

AI Kills the RCM Star: PE Should Be Wary of RCM Deals as Agentic AI Guts Take Rates

June 24, 2026

This analyst note examines how agentic AI and increasing competition are disrupting the RCM market, threatening PE investment returns as cost-to-collect rates compress and EHR-native rivals expand.

Research

Learn more »
Healthtech Quarterly

Healthtech VC Trends

April 30, 2026

The Q1 2026 Healthtech VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Healthtech Public Comp Sheet

Healthtech Public Comp Sheet and Valuation Guide

April 15, 2026

Our Healthtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded healthtech companies.

Research

Learn more »
Retail Health & Wellness Tech

The FDA’s U-turn on peptides could boost the next telehealth boom

April 1, 2026

New injectable peptides could take on a similar trajectory to GLP-1 drugs—but they’d come with risks.

Article

Learn more »
Healthtech

Linda Yaccarino’s GLP-1 telehealth unicorn raises $200M on adherence claim that bucks industry norm

March 26, 2026

EMed secures Series A at a $2B valuation. But will its adherence rate hold up at scale?

Article

Learn more »
Healthtech Quarterly

Healthtech VC Trends

February 25, 2026

The Q4 2025 Healthtech VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Healthcare Services Public Comp Sheet

Healthtech Public Comp Sheet and Valuation Guide

February 2, 2026

Our Healthtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded healthtech companies.

Research

Learn more »
VC Valuations

OpenEvidence hits $12B valuation as AI step-ups pull ahead

January 21, 2026

The $250M Series D doubles the valuation for the ‘ChatGPT for doctors’

Article

Learn more »
AI & ML

Meet the 10 most active VC investors in AI drug discovery

January 12, 2026

Globally, investors poured $3.8 billion into AI drug discovery startups in 2025.

Article

Learn more »
Venture Capital

These 10 VCs are betting the most on healthcare AI agent startups

January 9, 2026

Healthcare AI agent companies raised over $3.4 billion in 2025.

Article

Learn more »
AI Outlook

Artificial Intelligence Outlook: The Great Competition Wars Have Begun

December 9, 2025

Our 2026 Artificial Intelligence Outlook identifies the top AI subsectors to watch within our emerging technology verticals in the upcoming year.

Research

Learn more »
Healthcare Outlook

Healthcare Outlook

December 2, 2025

Our 2026 Healthcare Outlook forecasts trends that will shape the healthcare PE and VC ecosystems in the upcoming year.

Research

Learn more »
Healthcare Services Report

While healthtech deals rise, healthcare services falls

November 26, 2025

Many healthtech ventures have been formed to tackle the rising costs, revenue pressures and lower reimbursement rates affecting healthcare services providers.

Article

Learn more »
Healthtech Quarterly

Healthtech VC Trends

November 18, 2025

The Q3 2025 Healthtech VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Research

Learn more »
Healthtech Public Comp Sheet

Healthtech Public Comp Sheet and Valuation Guide

November 6, 2025

Our Q3 2025 Healthtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded healthtech companies.

Research

Learn more »
Healthtech

Oura’s valuation doubles to $11B as health tracking heats up

October 14, 2025

Oura, a Finnish maker of health tracking rings, is going head-to-head with fitness device giants like Apple and Garmin.

Article

Learn more »